Computational Pharmaceutics

7.5 credits

Course, Master's level, 3FG005

Expand the information below to show details on how to apply and entry requirements.

Location
Uppsala
Pace of study
100%
Teaching form
On-campus
Instructional time
Daytime
Study period
4 May 2026–7 June 2026
Language of instruction
English
Entry requirements

150 credits, including 120 credits in biomedicine, pharmaceutical sciences, drug development and/or natural sciences/engineering. Proficiency in English equivalent to the Swedish upper secondary course English 6.

Selection

Higher education credits in science and engineering (maximum 240 credits)

Fees
If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application and tuition fees.
  • First tuition fee instalment: SEK 18,125
  • Total tuition fee: SEK 18,125

Read more about fees.

Application deadline
15 October 2025
Application code
UU-89009

Admitted or on the waiting list?

Registration period
27 April 2026–3 May 2026
Information on registration from the department

Location
Uppsala
Pace of study
100%
Teaching form
On-campus
Instructional time
Daytime
Study period
4 May 2026–7 June 2026
Language of instruction
English
Entry requirements

150 credits, including 120 credits in biomedicine, pharmaceutical sciences, drug development and/or natural sciences/engineering. Proficiency in English equivalent to the Swedish upper secondary course English 6.

Admitted or on the waiting list?

Registration period
27 April 2026–3 May 2026
Information on registration from the department

Expand the information below to show details on how to apply and entry requirements.

Location
Uppsala
Pace of study
100%
Teaching form
On-campus
Instructional time
Daytime
Study period
3 May 2027–6 June 2027
Language of instruction
English
Entry requirements

150 credits, including 120 credits in biomedicine, pharmaceutical sciences, drug development and/or natural sciences/engineering. Proficiency in English equivalent to the Swedish upper secondary course English 6.

Selection

Higher education credits in science and engineering (maximum 240 credits)

Fees
If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application and tuition fees.
  • First tuition fee instalment: SEK 20,625
  • Total tuition fee: SEK 20,625

Read more about fees.

Application deadline
15 October 2026
Application code
UU-89009

Admitted or on the waiting list?

Information on registration from the department

Location
Uppsala
Pace of study
100%
Teaching form
On-campus
Instructional time
Daytime
Study period
3 May 2027–6 June 2027
Language of instruction
English
Entry requirements

150 credits, including 120 credits in biomedicine, pharmaceutical sciences, drug development and/or natural sciences/engineering. Proficiency in English equivalent to the Swedish upper secondary course English 6.

Admitted or on the waiting list?

Information on registration from the department

About the course

In the course, different simulation and modelling techniques (such as molecular dynamics, Monte Carlo, dissipative particle dynamics, and lattice-Boltzmann methodology) are studied, and how these can be used in the process of drug development. Examples include how in silico methods can be used for efficient design and understanding of pharmaceutical formulations e.g. biological drugs, and how modelling and simulation thereby can be used as a means toward less trial-and-error and more knowledge-based formulation development.

The course contains a basic understanding of physics-based simulation and modelling methodology, applicable to pharmaceutical and biological problems. In the course, the mathematical foundations for the lattice-Boltzmann method are presented, which is a way to model pharmaceutical systems at the intersection between individual molecules and macroscopic variables. Lattice-Boltzmann is applied later in the course to e.g. study the diffusion of drugs, formulation components and delivery systems under the influence of different external forces.

Further, an understanding is built during the course of the differences and similarities that exist between different simulation and modelling techniques, and examples are used to illustrate how the choice of a particular approach affects the conclusions that can be drawn around a specific pharmaceutical question.

A particular emphasis during the course is on physics-based modelling and simulation of orally administered drugs, especially therapeutic macromolecules such as peptides and proteins. These are studied both with and without any delivery system, to understand how innate molecular properties affect them and their interactions with each other (binding, structural changes), and also how such properties affect interactions with formulation components (e.g. permeation enhancers), and finally how these processes are affected by e.g. concentration gradients and the surrounding physiology.

FOLLOW UPPSALA UNIVERSITY ON

Uppsala University on Facebook
Uppsala University on Instagram
Uppsala University on Youtube
Uppsala University on Linkedin